Free Trial Information
BioCentury | Dec 20, 2010
Clinical News

Oncopore: Phase I started

...LTX-315 ) Business: Cancer Molecular target: NA Description: Synthetic lytic peptide developed from a pharmacore...
Read More
BioCentury | May 31, 2010
Clinical News

Oncopore: Phase I started

...LTX-315 ) Business: Cancer Molecular target: NA Description: Synthetic lytic peptide developed from a pharmacore...
Read More
BioCentury | Dec 21, 2009
Clinical News

Oncopore: Phase I start

...LTX-315 ) Business: Cancer Molecular target: NA Description: Synthetic lytic peptide developed from a pharmacore...
Read More
BioCentury | Jan 23, 2009
Financial News

Lytix raises $10.6 million

...treat skin infections; and Oncopore ( LTX-315 ), a synthetic lytic peptide developed from a pharmacore...
Read More
BioCentury | Aug 18, 2003
Company News

Spectral Genomics management update

...Genomics Inc. , Houston, Texas Business: Diagnostics/Imaging Hired: Ed Chait as CEO, formerly CEO of PharmaCore...
Read More
BioCentury | Aug 11, 2003
Company News

Chait named CEO of Spectral Genomics

...Prior to joining Spectral Genomics , Chait was CEO of small molecule drug discovery company PharmaCore...
Read More
BioCentury | Mar 31, 2003
Company News

Pharmacor, Procyon deal

Pharmacor it is being acquired by cancer and dermatology company PBP for 7 million PBP shares valued at C$2.8 million based on PBP’s Friday close at C$0.40. Pharmacor said the deal is contingent on its...
Read More
BioCentury | Aug 29, 2002
Company News

Vicore Pharma names Kvarnstrom CEO

...Vicore (formerly Pharmacore ) hired Ann-Christin Kvarnstrom as CEO. She was formerly VP of manufacturing strategy...
Read More
BioCentury | Jul 29, 2002
Company News

De Novo Pharmaceuticals, GeneFormatics deal

...the structure and chemistry of active sites. De Novo will use its Quasi II extended pharmacore...
Read More
BioCentury | Jul 8, 2002
Company News

Pharmacor management update

Pharmacor Inc. , Montreal, Quebec Business: Chemistry Hired: Heimo Scheer as VP of regulatory and clinical strategic alliances, formerly director of regulatory and technical services at Quintiles Transnational Corp. WIR Staff...
Read More
Items per page:
1 - 10 of 21
BioCentury | Dec 20, 2010
Clinical News

Oncopore: Phase I started

...LTX-315 ) Business: Cancer Molecular target: NA Description: Synthetic lytic peptide developed from a pharmacore...
Read More
BioCentury | May 31, 2010
Clinical News

Oncopore: Phase I started

...LTX-315 ) Business: Cancer Molecular target: NA Description: Synthetic lytic peptide developed from a pharmacore...
Read More
BioCentury | Dec 21, 2009
Clinical News

Oncopore: Phase I start

...LTX-315 ) Business: Cancer Molecular target: NA Description: Synthetic lytic peptide developed from a pharmacore...
Read More
BioCentury | Jan 23, 2009
Financial News

Lytix raises $10.6 million

...treat skin infections; and Oncopore ( LTX-315 ), a synthetic lytic peptide developed from a pharmacore...
Read More
BioCentury | Aug 18, 2003
Company News

Spectral Genomics management update

...Genomics Inc. , Houston, Texas Business: Diagnostics/Imaging Hired: Ed Chait as CEO, formerly CEO of PharmaCore...
Read More
BioCentury | Aug 11, 2003
Company News

Chait named CEO of Spectral Genomics

...Prior to joining Spectral Genomics , Chait was CEO of small molecule drug discovery company PharmaCore...
Read More
BioCentury | Mar 31, 2003
Company News

Pharmacor, Procyon deal

Pharmacor it is being acquired by cancer and dermatology company PBP for 7 million PBP shares valued at C$2.8 million based on PBP’s Friday close at C$0.40. Pharmacor said the deal is contingent on its...
Read More
BioCentury | Aug 29, 2002
Company News

Vicore Pharma names Kvarnstrom CEO

...Vicore (formerly Pharmacore ) hired Ann-Christin Kvarnstrom as CEO. She was formerly VP of manufacturing strategy...
Read More
BioCentury | Jul 29, 2002
Company News

De Novo Pharmaceuticals, GeneFormatics deal

...the structure and chemistry of active sites. De Novo will use its Quasi II extended pharmacore...
Read More
BioCentury | Jul 8, 2002
Company News

Pharmacor management update

Pharmacor Inc. , Montreal, Quebec Business: Chemistry Hired: Heimo Scheer as VP of regulatory and clinical strategic alliances, formerly director of regulatory and technical services at Quintiles Transnational Corp. WIR Staff...
Read More
Items per page:
1 - 10 of 21